Nathan Rich
Stock Analyst at Goldman Sachs
(1.18)
# 3,759
Out of 5,157 analysts
85
Total ratings
36.51%
Success rate
-9.97%
Average return
Main Sectors:
Stocks Rated by Nathan Rich
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HUM Humana | Maintains: Sell | $215 → $158 | $173.62 | -9.00% | 8 | Feb 17, 2026 | |
| OSCR Oscar Health | Maintains: Neutral | $16 → $21 | $13.30 | +57.89% | 6 | May 9, 2024 | |
| ZTS Zoetis | Maintains: Buy | $223 → $196 | $120.49 | +62.67% | 9 | May 6, 2024 | |
| XRAY DENTSPLY SIRONA | Maintains: Neutral | $34 → $30 | $12.68 | +136.59% | 8 | May 6, 2024 | |
| AMRX Amneal Pharmaceuticals | Maintains: Buy | $6.25 → $8 | $13.35 | -40.07% | 7 | May 6, 2024 | |
| NVST Envista Holdings | Maintains: Sell | $20 → $18 | $26.00 | -32.69% | 4 | May 3, 2024 | |
| ELAN Elanco Animal Health | Maintains: Sell | $13 → $14 | $23.67 | -40.85% | 9 | Feb 27, 2024 | |
| TEVA Teva Pharmaceutical Industries | Maintains: Neutral | $10 → $11 | $31.52 | -65.10% | 4 | Feb 5, 2024 | |
| ALGN Align Technology | Maintains: Sell | $197 → $225 | $169.43 | +32.80% | 2 | Feb 2, 2024 | |
| IDXX IDEXX Laboratories | Maintains: Buy | $500 → $650 | $598.85 | +8.54% | 3 | Jan 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $88 | $76.32 | +15.30% | 9 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $12 | $18.10 | -33.70% | 6 | Apr 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $93 → $85 | $76.29 | +11.42% | 1 | Jul 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $11 | $14.08 | -21.88% | 3 | May 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $335 | $141.32 | +137.05% | 1 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $535 | $282.34 | +89.49% | 5 | Dec 14, 2021 |
Humana
Feb 17, 2026
Maintains: Sell
Price Target: $215 → $158
Current: $173.62
Upside: -9.00%
Oscar Health
May 9, 2024
Maintains: Neutral
Price Target: $16 → $21
Current: $13.30
Upside: +57.89%
Zoetis
May 6, 2024
Maintains: Buy
Price Target: $223 → $196
Current: $120.49
Upside: +62.67%
DENTSPLY SIRONA
May 6, 2024
Maintains: Neutral
Price Target: $34 → $30
Current: $12.68
Upside: +136.59%
Amneal Pharmaceuticals
May 6, 2024
Maintains: Buy
Price Target: $6.25 → $8
Current: $13.35
Upside: -40.07%
Envista Holdings
May 3, 2024
Maintains: Sell
Price Target: $20 → $18
Current: $26.00
Upside: -32.69%
Elanco Animal Health
Feb 27, 2024
Maintains: Sell
Price Target: $13 → $14
Current: $23.67
Upside: -40.85%
Teva Pharmaceutical Industries
Feb 5, 2024
Maintains: Neutral
Price Target: $10 → $11
Current: $31.52
Upside: -65.10%
Align Technology
Feb 2, 2024
Maintains: Sell
Price Target: $197 → $225
Current: $169.43
Upside: +32.80%
IDEXX Laboratories
Jan 17, 2024
Maintains: Buy
Price Target: $500 → $650
Current: $598.85
Upside: +8.54%
May 4, 2023
Maintains: Buy
Price Target: $100 → $88
Current: $76.32
Upside: +15.30%
Apr 19, 2023
Maintains: Buy
Price Target: $14 → $12
Current: $18.10
Upside: -33.70%
Jul 21, 2022
Downgrades: Neutral
Price Target: $93 → $85
Current: $76.29
Upside: +11.42%
May 12, 2022
Maintains: Neutral
Price Target: $10 → $11
Current: $14.08
Upside: -21.88%
Dec 14, 2021
Initiates: Buy
Price Target: $335
Current: $141.32
Upside: +137.05%
Dec 14, 2021
Initiates: Buy
Price Target: $535
Current: $282.34
Upside: +89.49%